|
FR2291749A1
(fr)
*
|
1974-11-20 |
1976-06-18 |
Delalande Sa |
Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique
|
|
US6262040B1
(en)
*
|
1996-09-04 |
2001-07-17 |
Pfizer Inc |
Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF)
|
|
CA2419224A1
(en)
*
|
2000-09-15 |
2002-03-21 |
Anormed Inc. |
Chemokine receptor binding heterocyclic compounds
|
|
US7642277B2
(en)
*
|
2002-12-04 |
2010-01-05 |
Boehringer Ingelheim International Gmbh |
Non-nucleoside reverse transcriptase inhibitors
|
|
UY32138A
(es)
*
|
2008-09-25 |
2010-04-30 |
Boehringer Ingelheim Int |
Amidas sustituidas del ácido 2-(2,6-dicloro-fenilamino)-6-fluoro-1-metil-1h-bencimidazol-5-carboxílico y sus sales farmacéuticamente aceptables
|
|
US9550737B2
(en)
*
|
2012-06-11 |
2017-01-24 |
Ucb Biopharma Sprl |
TNF -α modulating benzimidazoles
|
|
US9458124B2
(en)
*
|
2013-02-06 |
2016-10-04 |
Wayne State University |
Substituted pyran derivatives
|
|
AU2016247768B2
(en)
*
|
2015-04-17 |
2019-03-07 |
Corteva Agriscience Llc |
Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
|
|
HUE064145T2
(hu)
*
|
2016-04-15 |
2024-03-28 |
Epizyme Inc |
Amin-szubsztituált aril- vagy heteroaril vegyületek, mint EHMT1 és EHMT2 inhibitorok
|
|
GB201610854D0
(en)
*
|
2016-06-21 |
2016-08-03 |
Entpr Therapeutics Ltd |
Compounds
|
|
GB201619694D0
(en)
*
|
2016-11-22 |
2017-01-04 |
Entpr Therapeutics Ltd |
Compounds
|
|
AU2018211529A1
(en)
*
|
2017-01-27 |
2019-08-29 |
Genfit |
N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxa zin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases
|
|
US11358947B2
(en)
*
|
2017-04-17 |
2022-06-14 |
The Regents Of The University Of California |
Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel TMEM16A
|
|
GB201801355D0
(en)
*
|
2018-01-26 |
2018-03-14 |
Enterprise Therapeutics Ltd |
Compounds
|